202 related articles for article (PubMed ID: 15737847)
1. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1.
Lin MT; Chang CC; Lin BR; Yang HY; Chu CY; Wu MH; Kuo ML
J Biol Chem; 2007 Nov; 282(47):34594-604. PubMed ID: 17905740
[TBL] [Abstract][Full Text] [Related]
3. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
[TBL] [Abstract][Full Text] [Related]
4. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.
Crockett JC; Schütze N; Tosh D; Jatzke S; Duthie A; Jakob F; Rogers MJ
Endocrinology; 2007 Dec; 148(12):5761-8. PubMed ID: 17823253
[TBL] [Abstract][Full Text] [Related]
5. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.
Gery S; Xie D; Yin D; Gabra H; Miller C; Wang H; Scott D; Yi WS; Popoviciu ML; Said JW; Koeffler HP
Clin Cancer Res; 2005 Oct; 11(20):7243-54. PubMed ID: 16243794
[TBL] [Abstract][Full Text] [Related]
6. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
Sampath D; Winneker RC; Zhang Z
Endocrinology; 2001 Jun; 142(6):2540-8. PubMed ID: 11356703
[TBL] [Abstract][Full Text] [Related]
7. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
8. Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis.
Haque I; Mehta S; Majumder M; Dhar K; De A; McGregor D; Van Veldhuizen PJ; Banerjee SK; Banerjee S
Mol Cancer; 2011 Jan; 10():8. PubMed ID: 21232118
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
11. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway.
Lin MT; Zuon CY; Chang CC; Chen ST; Chen CP; Lin BR; Wang MY; Jeng YM; Chang KJ; Lee PH; Chen WJ; Kuo ML
Clin Cancer Res; 2005 Aug; 11(16):5809-20. PubMed ID: 16115920
[TBL] [Abstract][Full Text] [Related]
12. Cyr61 suppresses growth of human endometrial cancer cells.
Chien W; Kumagai T; Miller CW; Desmond JC; Frank JM; Said JW; Koeffler HP
J Biol Chem; 2004 Dec; 279(51):53087-96. PubMed ID: 15471875
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
14. The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression.
Huang YT; Lan Q; Ponsonnet L; Blanquet M; Christofori G; Zaric J; Rüegg C
Oncotarget; 2016 Jan; 7(2):1663-74. PubMed ID: 26625209
[TBL] [Abstract][Full Text] [Related]
15. Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61.
Walsh CT; Radeff-Huang J; Matteo R; Hsiao A; Subramaniam S; Stupack D; Brown JH
FASEB J; 2008 Nov; 22(11):4011-21. PubMed ID: 18687805
[TBL] [Abstract][Full Text] [Related]
16. Cyr61 promotes breast tumorigenesis and cancer progression.
Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
[TBL] [Abstract][Full Text] [Related]
17. A Key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in Tumor cells.
Meyuhas R; Pikarsky E; Tavor E; Klar A; Abramovitch R; Hochman J; Lago TG; Honigman A
Mol Cancer Res; 2008 Sep; 6(9):1397-409. PubMed ID: 18819928
[TBL] [Abstract][Full Text] [Related]
18. A single bout of exercise with high mechanical loading induces the expression of Cyr61/CCN1 and CTGF/CCN2 in human skeletal muscle.
Kivelä R; Kyröläinen H; Selänne H; Komi PV; Kainulainen H; Vihko V
J Appl Physiol (1985); 2007 Oct; 103(4):1395-401. PubMed ID: 17673559
[TBL] [Abstract][Full Text] [Related]
19. Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.
Walters DM; Stokes JB; Adair SJ; Stelow EB; Borgman CA; Lowrey BT; Xin W; Blais EM; Lee JK; Papin JA; Parsons JT; Bauer TW
PLoS One; 2013; 8(10):e77065. PubMed ID: 24204737
[TBL] [Abstract][Full Text] [Related]
20. Cyr61-positive cancer stem-like cells enhances distal metastases of pancreatic cancer.
Shi W; Zhang C; Chen Z; Chen H; Liu L; Meng Z
Oncotarget; 2016 Nov; 7(45):73160-73170. PubMed ID: 27705906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]